These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9276374
1. Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation. Joon DL, Hasegawa M, Sikes C, Khoo VS, Terry NH, Zagars GK, Meistrich ML, Pollack A. Int J Radiat Oncol Biol Phys; 1997 Jul 15; 38(5):1071-7. PubMed ID: 9276374 [Abstract] [Full Text] [Related]
2. The early supra-additive apoptotic response of R3327-G prostate tumors to androgen ablation and radiation is not sustained with multiple fractions. Pollack A, Ashoori F, Sikes C, Joon DL, von Eschenbach AC, Zagars GK, Meistrich ML. Int J Radiat Oncol Biol Phys; 2000 Jan 01; 46(1):153-8. PubMed ID: 10656387 [Abstract] [Full Text] [Related]
3. Quiescence in R3327-G rat prostate tumors after androgen ablation. Pollack A, Joon DL, Wu CS, Sikes C, Hasegawa M, Terry NH, White RA, Zagars GK, Meistrich ML. Cancer Res; 1997 Jun 15; 57(12):2493-500. PubMed ID: 9192831 [Abstract] [Full Text] [Related]
4. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat. Brändström A, Westin P, Bergh A, Cajander S, Damber JE. Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987 [Abstract] [Full Text] [Related]
5. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT. Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749 [Abstract] [Full Text] [Related]
13. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma. Westin P, Brändström A, Damber JE, Bergh A. Br J Cancer; 1995 Jul 15; 72(1):140-5. PubMed ID: 7599043 [Abstract] [Full Text] [Related]
14. Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions. Røe K, Seierstad T, Kristian A, Mikalsen LT, Mælandsmo GM, van der Kogel AJ, Ree AH, Olsen DR. Neoplasia; 2010 Oct 15; 12(10):818-25. PubMed ID: 20927320 [Abstract] [Full Text] [Related]
16. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines. Fuerst J, Fiebiger E, Jungwirth A, Mack D, Talwar PG, Frick J, Rovan E. Prostate; 1997 Jul 01; 32(2):77-84. PubMed ID: 9215394 [Abstract] [Full Text] [Related]
17. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis. Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M. Cancer Res; 2005 Dec 01; 65(23):11083-93. PubMed ID: 16322258 [Abstract] [Full Text] [Related]
18. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour. Granfors T, Tomic R, Bergh A, Rydh M, Löfroth PO, Widmark A. Urol Res; 1999 Oct 01; 27(5):357-61. PubMed ID: 10550524 [Abstract] [Full Text] [Related]